NIH-funded research NIH-funded research

A virtual bank for collecting and sharing mesothelioma patient data and samples.

Official title: Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24) - 2021

Funded at University of Pittsburgh at Pittsburgh · NIH-10849611 · Data updated 2026-11-12

This study is gathering blood and tissue samples from people with mesothelioma to help researchers learn more about the disease and find better treatments, and they're looking to include more patients from different backgrounds to make the research even more helpful.

More Mesothelioma research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 1, 2021
Project endAugust 31, 2026
Funding year2024
Award (this year)$1,079,312
NIH project number5U24OH009077-18
Project IDNIH-10849611 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for participation are individuals diagnosed with mesothelioma who are willing to provide biospecimens and clinical information.

Less likely to help

Patients who do not have a diagnosis of mesothelioma or are unwilling to provide biospecimens may not benefit from this research.

What this research studies

The National Mesothelioma Virtual Bank (NMVB) collects biospecimens such as blood and tissue from patients diagnosed with mesothelioma, along with their demographic and clinical information. This data is shared with researchers to advance understanding and treatment of mesothelioma. The project aims to expand the patient cohort to 2,200 individuals and enhance the diversity of the data collected. Additionally, the NMVB seeks to automate the annotation of biospecimens using electronic health records to improve research efficiency.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments and outcomes for patients with mesothelioma.

How similar studies have gone: Previous research initiatives involving biobanks have shown success in advancing cancer research, indicating that this approach is promising.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Becich, Michael John — University of Pittsburgh at Pittsburgh
  • Study coordinator: Becich, Michael John

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.